New combination drug treatment may successfully treat cystic fibrosis
A combination of the drugs Kalydeco (ivacaftor) and lumacaftor, which has not yet been approved by the Food and Drug Administration (FDA), can successfully…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.